Inventor · disambiguated record
Manuel Rosa-Calatrava
Also filed as: ROSA-CALATRAVA MANUEL
9 granted patents·5 pending applications·15 citations·filing 2003–2023
82Inventor score
Files withUNIV CLAUDE BERNARD LYON7ROSA-CALATRAVA MANUEL2CALIXAR1CENTRE NAT RECH SCIENT1MOULES VINCENT1
Top patents by PatentIndex Score
14 records- 0181US11351180B2Antiviral compositions for treating the fluUNIV CLAUDE BERNARD LYON·Filed 2016·Granted Jun 7, 2022·3 cites·5 claims
- 0274US9433592B2Pharmaceutical or veterinary antiviral compositionsROSA-CALATRAVA MANUEL·Filed 2010·Granted Sep 6, 2016·4 cites·4 claims
- 0370US11504424B2Attenuated virus strain and use thereof as a vaccineUNIV CLAUDE BERNARD LYON·Filed 2019·Granted Nov 22, 2022·1 cites·10 claims
- 0469US9381238B2Method for improving the production of influenza viruses and vaccine seedsTERRIER OLIVIER·Filed 2011·Granted Jul 5, 2016·4 cites·17 claims
- 0563US11510896B2Antiviral compositions for the treatment of infections linked to coronavirusesUNIV CLAUDE BERNARD LYON·Filed 2017·Granted Nov 29, 2022·1 cites·8 claims
- 0657US12285433B2Diltiazem for use in the treatment of microbial infectionsUNIV CLAUDE BERNARD LYON·Filed 2019·Granted Apr 29, 2025·0 cites·6 claims
- 0756US2025195637A1Vaccine composition against two respiratory virusesVAXXEL·Filed 2023·Application pending·0 cites
- 0855US12440498B2Combination of diltiazem and viral polymerase inhibitorsUNIV CLAUDE BERNARD LYON·Filed 2021·Granted Oct 14, 2025·0 cites·25 claims
- 0952US10144917B2Method for preparing a vaccine antigen, resulting vaccine antigen and usesCALIXAR·Filed 2015·Granted Dec 4, 2018·1 cites·11 claims
- 1052US2024307431A1Novel sialosides and their use in therapyCENTRE NAT RECH SCIENT·Filed 2022·Application pending·0 cites
- 1150US8956626B2Modified viral strains and method for improving the production of vaccine seeds of influenza virusMOULES VINCENT·Filed 2011·Granted Feb 17, 2015·1 cites·14 claims
- 1246US2022054618A1Production of viral vaccines on an avian cell lineUNIV CLAUDE BERNARD LYON·Filed 2019·Application pending·0 cites
- 1346US2023210866A1Composition comprising diltiazem for treating a viral infection caused by sars-cov-2 virusesUNIV CLAUDE BERNARD LYON·Filed 2021·Application pending·0 cites
- 1434US2006228334A1Modified adenoviral fiber with ablated to cellular receptorsROSA-CALATRAVA MANUEL·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuel Rosa-Calatrava files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →